ArticleBMJ open2026
Prevalence of depression among adult psoriatic patients in Palestine: a cross-sectional study in primary healthcare settings.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPsoriasis is a chronic inflammatory skin disease associated with substantial psychosocial burden and an elevated risk of depression.
objectivesThis study aimed to estimate the prevalence of depression among adult psoriasis patients and to identify associated demographic, clinical and psychosocial factors.
methodsA cross-sectional study was conducted between March and September 2025 across governmental dermatology clinics in the West Bank. A total of 320 adult patients with psoriasis completed interviewer-assisted Arabic questionnaires with a response rate of 92.5%. Depression was assessed using the validated Patient Health Questionnaire-9 (score ≥10 indicating depression). Psoriasis severity and psychosocial impact were evaluated using the self-administered Simplified Psoriasis Index. Multivariate logistic regression was used to identify independent predictors of depression.
resultsThe prevalence of depression was 33.1% based on a screening tool (95% CI 28.0% to 38.6%). In multivariate analysis, lower educational attainment (elementary/middle school vs university: adjusted OR (aOR)=2.6; 95% CI 1.3 to 5.4; p=0.013) and higher psychosocial impact score (aOR=1.3; 95% CI 1.1 to 1.4; p<0.001) were independently associated with depression. Female sex demonstrated a borderline, non-significant association with depression (aOR=1.7; p=0.064). Notably, clinical severity of psoriasis was not a significant predictor after adjustment, although 50% of patients with severe disease screened positive for depression. Pruritus was prevalent (79.7%) and significantly associated with depression in univariate analysis.
conclusionsDepression affects approximately one in three patients with psoriasis in this primary care setting, associated more closely with psychosocial burden and socioeconomic factors than with clinical disease severity. These findings underscore the critical need for routine depressive symptom screening and integrated mental health support within dermatological care, particularly in conflict-affected and resource-limited regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.